CJC-1295 (with DAC)
Long-acting GHRH analog with Drug Affinity Complex for sustained GH elevation.
- Typical dose
- 1 mg – 2 mg
- Frequency
- once weekly
- Route
- Subcutaneous
- Half-life
- 8 days
- Routes
- Subcutaneous
- Status
- Research chemical
Benefits
- Sustained GH elevation
- Convenience (weekly dosing)
- Fat loss
- Muscle growth
Dosing
A common research range for CJC-1295 (with DAC) is 1 mg to 2 mg once weekly. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Reconstitution
A typical reconstitution for CJC-1295 (with DAC) is 2 mg of peptide in 2 mL of bacteriostatic water, giving roughly 1 mg per mL. Vial's built-in calculator works out the exact syringe draw for any vial size and dose.
Half-life
CJC-1295 (with DAC) has an approximate half-life of 8 days. Vial can display informational half-life estimates when supported data is available. These estimates are not measured blood concentrations or dosing instructions.
Storage
2-8°C post-reconstitution.
Reported side effects
- Water retention
- Tingling/numbness
- Elevated cortisol
Contraindications
- Active malignancy
Commonly stacked with
Track CJC-1295 (with DAC) with Vial
Vial logs every CJC-1295 (with DAC) dose, organizes your schedule, and offers reconstitution math and supported half-life estimates. Tracking records stay on your device. A Vial Pro subscription is required. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. CJC-1295 (with DAC) is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.